Clinical Trial Update: A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating how GLP-1 receptor signaling influences glucagon-stimulated insulin secretion in healthy subjects; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Snippet

Sponsor: Adrian Vella | Conditions: Healthy | Phase 3 | Status: COMPLETED | Results posted: 2023-06-09